Dormant cancer cells can ‘wake up’ after decades
28 May 2015 | By Victoria White
Researchers have found genetic evidence that dormant cancer cells can avoid the effects of treatment only to ‘wake up’ many years later...
List view / Grid view
News
Blocking LOX enzyme could prevent breast cancer from spreading
28 May 2015 | By Victoria White
Scientists have identified an enzyme, LOX, that possibly holds the key to preventing secondary cancers in breast cancer patients...
Merozyne Therapeutics launches project to develop a treatment for patients with MDC1A
27 May 2015 | By Victoria White
Merozyne has started a project to develop a pharmaceutical treatment against laminin alpha2 chain-deficient congenital muscular dystrophy (MDC1A)...
Achilles’ heel of Ebola virus identified in new study
27 May 2015 | By Victoria White
An international team of scientists has identified the molecular “lock” that the deadly Ebola virus must pick to gain entry to cells...
An interview with Ben Busby, National Center for Biotechnology Information (NCBI)
26 May 2015 | By Oxford Global Conferences
In the run up to the Next Generation Sequencing USA Congress & co-located Single Cell Genomics and Transcriptomics USA Congress, Oxford Global Conferences interviewed Ben Busby, Genomics Outreach Coordinator, NCBI...
TSRI chemists devise inexpensive method for synthesising amines
26 May 2015 | By Victoria White
Chemists at The Scripps Research Institute (TSRI) have discovered a broad and strikingly inexpensive method for synthesising amines...
Eisai to promote clinical trial data disclosure for the advancement of science and medicine
26 May 2015 | By Victoria White
In order to promote transparency in clinical trial data disclosure, Eisai is making its clinical trial data available to researchers via an external website...
Anti-stroke drug Vinpocetine could be effective as a treatment for middle-ear infections
22 May 2015 | By Victoria White
Vinpocetine is an effective treatment for middle-ear infections, showing the ability to improve bacterial clearance and reduce hearing loss...
Janssen and Achillion enter into worldwide collaboration to combat Hepatitis C
22 May 2015 | By Victoria White
Achillion and Janssen have entered into a worldwide license and collaboration arrangement to develop and commercialise one or more of Achillion's HCV assets...
Eureka Therapeutics and Boehringer Ingelheim enter into antibody research agreement
22 May 2015 | By Victoria White
Eureka Therapeutics and Boehringer Ingelheim have entered into a research agreement for the discovery of novel therapeutic antibodies in oncology...
Scientists unveil ‘Rosetta Stone’ of prostate cancer
21 May 2015 | By Victoria White
Almost 90% of men with advanced prostate cancer carry genetic mutations in their tumours that could be targeted by either existing or new cancer drugs...
Re-engineered spectinomycin shows potential for treatment of drug-resistant bacteria
21 May 2015 | By Victoria White
Researchers have developed a second-generation of spectinomycin that shows early effectiveness against common bacterial infections...
Alnylam files Clinical Trial Application for ALN-AAT for the treatment of Alpha-1 Liver Disease
21 May 2015 | By Victoria White
Alnylam has filed a Clinical Trial Application to initiate a Phase 1/2 clinical trial with ALN-AAT for the treatment of alpha-1 liver disease...
Orphan Drug Designation granted in the EU for ISTH0036 to treat advanced-stage glaucoma
21 May 2015 | By Victoria White
The EMA has granted orphan drug designation for ISTH0036, a locked nucleic acid-modified antisense oligonucleotide, to treat advanced-stage glaucoma...
First cancer-promoting oncogenes discovered in choroid plexus carcinoma
21 May 2015 | By Victoria White
Researchers have identified three genes that play a pivotal role in choroid plexus carcinoma, a discovery that could lead to more effective treatment...
